The Recall Desk
SevereFDA (Devices)·Z-1775-2023·Announced 2023-06-28

Medtronic Implantable Cardioverter Defibrillator Model DTPA2D1G Therapy Output Failure

Medtronic Inc. is recalling five units of the CRTD DTPA2D1G COBALT XT HF QUAD OUS implantable cardioverter defibrillator due to a rare potential for reduced or no energy output during high-voltage defibrillation therapy.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This device is subject to an FDA Class I recall; however, no deaths or serious injuries have been reported and the hazard is described as a rare potential for device failure, preventing a Critical classification.

Plain-English summary

Medtronic Inc. is recalling five units of the CRTD DTPA2D1G COBALT XT HF QUAD OUS implantable cardioverter defibrillator (model DTPA2D1G). The devices are affected by a rare potential for reduced or no energy output during high-voltage therapy, typically in the 0-12 joule range.

The affected devices contain a specific glassed feedthrough component that may cause this malfunction. The recalled units have the following lot serial numbers: RTH602452S, RTH602446S, RTH602443S, RTH602454S, and RTH602442S. These devices were distributed nationwide in the United States and worldwide.

The recalled product

Product
CRTD DTPA2D1G COBALT XT HF QUAD OUS, Model Number DTPA2D1G; Implantable Cardioverter Defibrillators
Manufacturer
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Hazard
  • device-malfunction
  • therapy-failure

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • GTIN 00763000501044
  • lot serial Numbers: RTH602452S
  • RTH602446S
  • RTH602443S
  • RTH602454S
  • RTH602442S

Distribution

Distributed nationwide across the United States.